161 related articles for article (PubMed ID: 37085611)
1. UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia.
Duployez N; Vasseur L; Kim R; Largeaud L; Passet M; L'Haridon A; Lemaire P; Fenwarth L; Geffroy S; Helevaut N; Celli-Lebras K; Adès L; Lebon D; Berthon C; Marceau-Renaut A; Cheok M; Lambert J; Récher C; Raffoux E; Micol JB; Pigneux A; Gardin C; Delabesse E; Soulier J; Hunault M; Dombret H; Itzykson R; Clappier E; Preudhomme C
Leukemia; 2023 Jun; 37(6):1245-1253. PubMed ID: 37085611
[TBL] [Abstract][Full Text] [Related]
2. UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome.
Georgi JA; Stasik S; Eckardt JN; Zukunft S; Hartwig M; Röllig C; Middeke JM; Oelschlägel U; Krug U; Sauer T; Scholl S; Hochhaus A; Brümmendorf TH; Naumann R; Steffen B; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Hänel M; Noppeney R; Kaiser U; Baldus CD; Kaufmann M; Müller-Tidow C; Platzbecker U; Berdel WE; Serve H; Ehninger G; Bornhäuser M; Schetelig J; Kroschinsky F; Thiede C;
Blood Cancer J; 2023 May; 13(1):88. PubMed ID: 37236968
[TBL] [Abstract][Full Text] [Related]
3. UBTF-internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia.
Kaburagi T; Shiba N; Yamato G; Yoshida K; Tabuchi K; Ohki K; Ishikita E; Hara Y; Shiraishi Y; Kawasaki H; Sotomatsu M; Takizawa T; Taki T; Kiyokawa N; Tomizawa D; Horibe K; Miyano S; Taga T; Adachi S; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2023 Apr; 62(4):202-209. PubMed ID: 36448876
[TBL] [Abstract][Full Text] [Related]
4. Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia.
Umeda M; Ma J; Huang BJ; Hagiwara K; Westover T; Abdelhamed S; Barajas JM; Thomas ME; Walsh MP; Song G; Tian L; Liu Y; Chen X; Kolekar P; Tran Q; Foy SG; Maciaszek JL; Kleist AB; Leonti AR; Ju B; Easton J; Wu H; Valentine V; Valentine MB; Liu YC; Ries RE; Smith JL; Parganas E; Iacobucci I; Hiltenbrand R; Miller J; Myers JR; Rampersaud E; Rahbarinia D; Rusch M; Wu G; Inaba H; Wang YC; Alonzo TA; Downing JR; Mullighan CG; Pounds S; Babu MM; Zhang J; Rubnitz JE; Meshinchi S; Ma X; Klco JM
Blood Cancer Discov; 2022 May; 3(3):194-207. PubMed ID: 35176137
[TBL] [Abstract][Full Text] [Related]
5.
Barajas JM; Umeda M; Contreras L; Khanlari M; Westover T; Walsh MP; Xiong E; Yang C; Otero B; Arribas-Layton M; Abdelhamed S; Song G; Ma X; Thomas ME; Ma J; Klco JM
medRxiv; 2023 Nov; ():. PubMed ID: 38014207
[TBL] [Abstract][Full Text] [Related]
6.
Barajas JM; Umeda M; Contreras L; Khanlari M; Westover T; Walsh MP; Xiong E; Yang C; Otero B; Arribas-Layton M; Abdelhamed S; Song G; Ma X; Thomas Rd ME; Ma J; Klco JM
Haematologica; 2024 Feb; ():. PubMed ID: 38426285
[TBL] [Abstract][Full Text] [Related]
7. Frequency of FLT3 Internal Tandem Duplications in Adult Syrian Patients with Acute Myeloid Leukemia and Normal Karyotype.
Al-Arbeed IF; Wafa A; Moassass F; Al-Halabi B; Al-Achkar W; Abou-Khamis I
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3245-3251. PubMed ID: 34711001
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM
Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998
[TBL] [Abstract][Full Text] [Related]
9. Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment.
Fleischmann M; Schnetzke U; Schrenk KG; Schmidt V; Sayer HG; Hilgendorf I; Hochhaus A; Scholl S
J Cancer Res Clin Oncol; 2017 Feb; 143(2):337-345. PubMed ID: 27778197
[TBL] [Abstract][Full Text] [Related]
10. High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group.
Shimada A; Taki T; Koga D; Tabuchi K; Tawa A; Hanada R; Tsuchida M; Horibe K; Tsukimoto I; Adachi S; Kojima S; Hayashi Y
Int J Hematol; 2012 Oct; 96(4):469-76. PubMed ID: 22915059
[TBL] [Abstract][Full Text] [Related]
11. Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
Paschka P; Marcucci G; Ruppert AS; Whitman SP; Mrózek K; Maharry K; Langer C; Baldus CD; Zhao W; Powell BL; Baer MR; Carroll AJ; Caligiuri MA; Kolitz JE; Larson RA; Bloomfield CD
J Clin Oncol; 2008 Oct; 26(28):4595-602. PubMed ID: 18559874
[TBL] [Abstract][Full Text] [Related]
12. Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AML.
Buelow DR; Pounds SB; Wang YD; Shi L; Li Y; Finkelstein D; Shurtleff S; Neale G; Inaba H; Ribeiro RC; Palumbo R; Garrison D; Orwick SJ; Blachly JS; Kroll K; Byrd JC; Gruber TA; Rubnitz JE; Baker SD
Clin Transl Sci; 2019 Nov; 12(6):641-647. PubMed ID: 31350825
[TBL] [Abstract][Full Text] [Related]
13. Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin inhibitors.
Barajas JM; Rasouli M; Umeda M; Hiltenbrand R; Abdelhamed S; Mohnani R; Arthur B; Westover T; Thomas ME; Ashtiani M; Janke LJ; Xu B; Chang TC; Rosikiewicz W; Xiong E; Rolle C; Low J; Krishan R; Song G; Walsh MP; Ma J; Rubnitz JE; Iacobucci I; Chen T; Krippner-Heidenreich A; Zwaan CM; Heidenreich O; Klco JM
Blood; 2024 Feb; 143(7):619-630. PubMed ID: 37890156
[TBL] [Abstract][Full Text] [Related]
14. The prognosis predictive value of FMS-like tyrosine kinase 3-internal tandem duplications mutant allelic ratio (FLT3-ITD MR) in patients with acute myeloid leukemia detected by GeneScan.
Lyu M; Liao H; Shuai X; Jin Y; Su J; Zheng Q
Gene; 2020 Feb; 726():144195. PubMed ID: 31669649
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance].
Wang YG; Liu XH; Liang Y; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):741-5. PubMed ID: 19176010
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcomes in patients with acute myeloid leukemia with concurrent FLT3-ITD and IDH mutations.
Shoukier M; Kadia T; Konopleva M; Alotaibi AS; Alfayez M; Loghavi S; Patel KP; Kanagal-Shamanna R; Cortes J; Samra B; Jabbour E; Garcia-Manero G; Takahashi K; Pierce S; Short NJ; Yilmaz M; Sasaki K; Masarova L; Pemmaraju N; Borthakur G; Kantarjian HM; Ravandi F; DiNardo CD; Daver N
Cancer; 2021 Feb; 127(3):381-390. PubMed ID: 33119202
[TBL] [Abstract][Full Text] [Related]
17. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
18. [FMS-like tyrosine kinase 3 gene mutations in acute myeloid leukemia].
Han YL; Zhang SJ; Qiao C; Dai D; Sun XM; Xu YL; Qian SX; Xu W; Wang JS; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1135-9. PubMed ID: 19840437
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3.
Zhang C; Lam SSY; Leung GMK; Tsui SP; Yang N; Ng NKL; Ip HW; Au CH; Chan TL; Ma ESK; Yip SF; Lee HKK; Lau JSM; Luk TH; Li W; Kwong YL; Leung AYH
Cancer; 2020 Jan; 126(2):344-353. PubMed ID: 31580501
[TBL] [Abstract][Full Text] [Related]
20. Outcome of Childhood Acute Myeloid Leukemia With FLT3-ITD Mutation: The Experience of Children's Cancer Hospital Egypt, 2007-17.
Semary SF; Hammad M; Soliman S; Yassen D; Gamal M; Albeltagy D; Hamdy N; Mahmoud S
Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):e529-e541. PubMed ID: 32473792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
